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Abstract: The Third Annual Meeting of the European Virus Bioinformatics Center (EVBC) took
place in Glasgow, United Kingdom, 28–29 March 2019. Virus bioinformatics has become central to
virology research, and advances in bioinformatics have led to improved approaches to investigate
Viruses 2019, 11, 420; doi:10.3390/v11050420 www.mdpi.com/journal/viruses
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viral infections and outbreaks, being successfully used to detect, control, and treat infections of
humans and animals. This active field of research has attracted approximately 110 experts in virology
and bioinformatics/computational biology from Europe and other parts of the world to attend the
two-day meeting in Glasgow to increase scientific exchange between laboratory- and computer-based
researchers. The meeting was held at the McIntyre Building of the University of Glasgow; a perfect
location, as it was originally built to be a place for “rubbing your brains with those of other people”,
as Rector Stanley Baldwin described it. The goal of the meeting was to provide a meaningful and
interactive scientific environment to promote discussion and collaboration and to inspire and suggest
new research directions and questions. The meeting featured eight invited and twelve contributed
talks, on the four main topics: (1) systems virology, (2) virus-host interactions and the virome, (3) virus
classification and evolution and (4) epidemiology, surveillance and evolution. Further, the meeting
featured 34 oral poster presentations, all of which focused on specific areas of virus bioinformatics.
This report summarizes the main research findings and highlights presented at the meeting.
Keywords: virology; virus bioinformatics; software; systems virology; metagenomics; virome; viral
taxonomy; virus classification; genome evolution; bacteriophage; virosphere
1. Introduction
The European Virus Bioinformatics Center (EVBC) was conceived of in 2017 to bring together
experts in virology and virus bioinformatics in Europe [1,2]. EVBC’s member numbers have increased
steadily since then with currently 151 members from 78 research institutions distributed over
26 countries across Europe and internationally. This spring, the Annual Meeting of the EVBC was
held for the third time (Table 1). The Third Annual Meeting of the EVBC attracted experts at all career
stages to attend the two-day meeting in Glasgow in an inspiring and interactive scientific environment
to promote discussion, exchange of ideas and collaboration and to inspire and suggest new research
directions and opportunities.
Table 1. History of the Annual Meeting of the European Virus Bioinformatics Center(EVBC).
Date Location # of Participants Key outcomes
6–8 March 2017 Friedrich Schiller
University Jena,
Germany
~100 Founding of the Center;
Discussion of the role of EVBC;
Election of the first Board of Directors;
Insights into EU policy and funding opportunities.
9–10 April 2018 Utrecht University,
Netherlands
~120 Extending of the EVBC network to include America
and Asia;
Discussion and design of joint projects;
Insights on first applied European fund among
EVBC members [3].
28–29 March 2019 University of
Glasgow,
United Kingdom
~110 Inclusion of contributed talks in themed sections in
the scientific programme;
Establishment of travel, poster and best contributed
talk awards for junior scientists;
Need for greater coordination and communication
within the European virology community.
2. Sessions and Oral Presentations
During the two-day conference, about 110 participants from 20 countries contributed in productive
discussion on the four topics: (1) systems virology, (2) virus-host interactions and the virome,
(3) virus classification and evolution and (4) epidemiology, surveillance and evolution. A number
of high quality presentations were given by leading virologists and junior scientists. In addition
to the eight invited speakers, we had twelve talks selected from the contributed submissions (see
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http://evbc.uni-jena.de/events/3rd-evbc-meeting). It was clear that the distinction between
laboratory and computer researchers is often blurred. That collaborating teams of individuals with
different skill sets are often a road to success, while individuals working alone can still make massive
contributions. Data-driven research is now mainstream, and the scale and complexity of datasets
is ever increasing. Discussions highlighted how virology, like all of biology, is now a data science,
exploiting methods from dimensionality reduction of large datasets to data visualisation. We took
from this that virus bioinformatics is evolving and succeeding as an area of research in its own right
at the interface of virology and computer science and that there are many ways to be a successful
researcher.
2.1. Systems Virology
This session was chaired by Philippe Le Mercier (University of Geneva Medical School,
Switzerland), board member of the EVBC. Two speakers have been invited on this topic. Volker
Thiel (University of Bern, Switzerland), board member of the EVBC, presented about host proteins
composing the microenvironment of coronavirus replicase complexes. EVBC member Stefanie
Deinhardt-Emmer (Jena University Hospital, Germany) presented about co-infection between
Staphylococcus aureus and influenza virus. From the submitted abstracts, we selected talks by Jenna
Nicole Kelly (University of Bern, Switzerland) on single-cell analysis of influenza virus infection,
Florian Erhard (University of Würzburg, Germany) on tools revealing core features of CMV-induced
regulation in single cells and Daniel Blanco Melo (Icahn School of Medicine at Mount Sinai, New York,
USA) on in-depth transcriptomic analysis in influenza A virus infection. Studying virus infections at
the molecular level is as complex as studying the host systems they infect.
2.1.1. Determination of Host Proteins Composing the Microenvironment of Coronavirus Replicase
Complexes, by Volker Thiel
Coronaviruses are positive-sense RNA viruses that infect a variety of mammalian and avian
species and are mainly associated with respiratory and enteric diseases. In humans, there are
four coronaviruses known to cause rather mild respiratory symptoms; however, the appearance
of zoonotic viruses, such as the Severe Acute Respiratory Syndrome (SARS) and Middle East
Respiratory Syndrome (MERS) coronaviruses, exemplified that coronaviruses can also cause severe
and lethal diseases in humans. Within their target cells, coronaviruses replicate their RNA genome at
host-derived membranes in the host cell cytoplasm. The Replicase Complex (RC) that is synthesizing
the viral RNA is encoded on the genomic RNA and comprises a set of 15–16 non-structural proteins
(nsps). Besides canonical functions associated with RNA synthesis, such as RNA-dependent RNA
polymerase, helicase and methyltransferases, a wealth of additional enzymatic activities, such as
endoribonuclease, ADP-ribosylation and de-ubiquitination, are included within the coronaviral RC,
suggesting that various virus–host interactions are taking place at the site of viral RNA synthesis.
However, our knowledge about host factors at the interface between the RC and the host cell cytoplasm
is rudimentary. To identify the composition of the viral RC and adjacent host cell proteins composing
the RC-microenvironment, we engineered a biotin ligase into a coronaviral RC. This allowed us to
biotinylate, affinity-purify and identify specifically all viral components constituting the coronavirus
RC and host cell proteins that are in close proximity (Figure 1). Amongst the >500 host proteins
constituting the RC-microenvironment, we identified numerous proteins associated with vesicular
trafficking pathways, ubiquitin-dependent and autophagy-related processes and translation initiation.
Notably, following the detection of translation initiation factors at the RC, we were able to visualize
and demonstrate active translation proximal to the site of viral RNA synthesis of several coronaviruses.
Collectively, our work established a spatial link between viral RNA synthesis and diverse host factors
of unprecedented breadth. Many of the coronavirus RC-proximal host proteins and pathways have
also documented roles in the life cycle of other positive-stranded RNA viruses, suggesting considerable
commonalities and conserved virus-host interactions at the RCs of a broad range of RNA viruses.
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Our data may thus serve as a paradigm for other RNA viruses and provide a starting point for
a comprehensive analysis of critical virus-host interactions that represent targets for therapeutic
intervention [4].
Figure 1. Illustration of the experimental design to determine the microenvironment of coronavirus
Replicase Complexes (RCs) (adapted from V’kovski et al. [4]).
2.1.2. Co-Infection between Staphylococcus aureus and Influenza Virus Reduces Endothelial Barrier
Function, by Stefanie Deinhardt-Emmer
Pneumonia is the most serious inflammatory disease of the respiratory tract and also the most
common infectious disease. The classification of pneumonia into Hospital-Acquired Pneumonia
(HAP), Community-Acquired Pneumonia (CAP) and Ventilated-Acquired Pneumonia (VAP) indicates
the source of disease by a wide variety of microorganisms including bacteria, viruses and fungi.
Respiratory tract infections and in particular pneumonia represent the most common cause of
sepsis [5]. Long-time associated with bacterial infection, sepsis definition became more in focus
as a multifaceted host response to an infecting pathogen, which leads to organ failure [6]. However,
Influenza Virus (IV) as a pneumotropic virus can lead to lung failure and systemic host reaction with
subsequent multiple organ failure. IV circulates worldwide and causes highly contagious respiratory
diseases characterized by mild to severe symptoms. The seasonal IV-associated bronchopneumonia
is one of these infectious diseases with the highest population-based mortality rates [7]. Besides
virulence factors, the sudden increase of pathogenicity is the most striking problem of influenza
accompanied by bacterial co-infection. In a single-centre study conducted at the Jena University
Hospital during the winter season 2017/2018, we detected 1197 influenza-virus-positive samples
and 89 S. aureus-positive respiratory specimens. However, the diagnosis of a co-infection was
significantly lower with 17 samples. Interestingly, the mortality rate increased dramatically from
single infection (approximately 20%) to co-infection (approximately 80%). Even larger studies
indicating similarly dates and also the Spanish flu of 1918 showed that co-infection results in
high mortality rates [8]. While the pathogen–host interaction-induced severe dysregulations of
the immune response is under investigation in many studies, the regulatory effects between the
different pathogens and the subsequent impact on the host are barely understood. In a multifactorial
process, a wide range of pathogen factors and pathogen-regulated signalling events are involved in
co-pathogenesis. This process is associated with elevated host-response, changed repair-processes,
and modifications in the cellular immune response [9]. It is shown that primary IV-infection inhibits
the apoptosis mechanism and the following infection with S. aureus inhibits IV-induced apoptosis
by procaspase-8 activation [10]. Various models are available for studying the mechanisms of the
viral–bacterial interference. However, the use of murine models is adversely regarded because of
obvious discrepancies between men and mice despite the attempts of humanized murine models to
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fill the gaps. New methods enable investigations with cost-saving and efficient cell culture models as
an excellent supplement to animal experiments. Organ-on-a-chip technology allows species-specific
investigations for different cell types and also immune cells. Using this method, viral-bacterial
interference can be investigated in a human-specific manner.
2.1.3. Single Cell Analysis of iNfluenza Virus Infection in Its Natural Target Cells Reveals Cell
Type-Specific Host Responses and Disparate Viral Burden, by Jenna Nicole Kelly
The human respiratory epithelium is a pseudostratified epithelium that constitutes the first line of
defence against invading respiratory pathogens, including influenza viruses. Although several studies
have now shown that both viral transcript production and the innate immune response to infection
vary widely among single influenza-infected cells, the cause of this extreme heterogeneity remains
unclear [11,12]. More specifically, it remains unknown how key innate immune components are
distributed among the different cell populations found in the respiratory epithelium and how the latter
may influence the host response to infection. To determine the distribution of these innate immune
components and to examine how specific cell types respond to influenza infection, we used single-cell
RNA sequencing to acquire transcriptomes from primary human Airway Epithelial Cells (hAEC)
infected with Influenza A Virus (IAV) (Figure 2) [13]. A low MOI was used to infect hAECs with either
Wild-Type (WT) pandemic IAV or an NS1mutated form of the virus (NS1R38A) that impairs its ability
to counteract Interferon (IFN) and produces an amplified innate immune response. We then annotated
both host and viral transcriptomes of more than 19,000 single cells across the five major hAEC cell types
for mock, WT, and NS1R38A conditions. We observed a large heterogeneity in viral burden; however,
in contrast to what was found in previous studies, no absence of viral genes was detected. Interestingly,
in both WT- and NS1R38A-infected cultures, there was a significant decrease in the fraction of ciliated
and goblet cells compared to mock hAECs. We also identified a number of cell-type-specific innate
immune responses, including the expression of type I and III IFNs in all major cell types. Collectively,
our results represent the first comprehensive report on how individual cells contribute to the antiviral
response during IAV infection in the context of the human respiratory epithelium.
Figure 2. Sequencing and annotation workflow for single influenza-infected cells in the human
respiratory epithelium. hAEC, human Airway Epithelial Cells.
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2.2. Virus–Host Interactions and the Virome
This session was chaired by David Robertson (MRC-University of Glasgow Centre for Virus
Research, United Kingdom), the local organizer of the meeting. Bacteriophages, the viruses of bacteria,
are an important and usually neglected component of microbiome studies. Two speakers have been
invited on this topic. Martha Clokie (University of Leicester, United Kingdom) presented about the
roles of phages in impacting infectious diseases in human microbiomes. EVBC member Bas Dutilh
(Utrecht University, Netherlands) presented about global phylogeography and the ancient evolution
of the widespread human gut virus crAssphage. From the submitted abstracts, we selected talks
by Katherine Brown (University of Cambridge, United Kingdom) on viral transcripts in RNA-seq
datasets from bees, mites, and ants, Evelien Adriaenssens (Quadram Institute Bioscience, Norwich,
United Kingdom) on genome-resolved metaviromics for the detection of pathogenic viruses in the
environment and Josquin Daron (Centre National de la Recherche Scientifique, Montpellier, France) on
codon usage preference similarity among human-infecting viruses and their hosts.
2.2.1. Roles of Phages in Impacting Infectious Diseases in Human Microbiomes, by R. J. Martha Clokie
Most of the roles of phages in human health and disease are yet to be unravelled. However,
phages in all environments including the human microbiome are increasingly acknowledged to be
the puppeteers of their bacterial hosts, shaping their structure and evolution and physiology. Phages
associated with bacterial pathogens have multiple, often complex interactions with their bacterial
hosts, forcing them to interact differently with other bacterial and human cells. Besides being the
ultimate bacterial killers, phages can change bacterial surfaces to prevent recognition by the human
immune system. In cystic fibrosis, they can allow their hosts to cope with anaerobic conditions found
in mucus-laden lungs, and in many bacteria, they encode potent toxins [14]. There is indeed a plethora
of unknown phage-mediated bacterial phenotypes that could be critical for our understanding of
disease. Their ability to be developed as targeted removers of pathogenic bacteria is likely to be critical
to solving the antimicrobial resistance crisis.
A major limitation for our ability to develop therapeutic phages and also understand fully the
ways that phages impact bacteria is that the vast majority of phage gene functions are hypothetical or
unknown. In bacterial genomes, there are around 25% unknown genes, or genes that have no known
ascribed function, but in phage genomes, only around 25% of the genes are generally known! Thus,
when trying to establish how phages specifically interact with their hosts, there is large number of
genes of which we need to try and make sense.
To illustrate the diversity within one specific phage set, Martha Clokie presented the work from
her lab on phages that infect the gut pathogen Clostridium difficile [15–17]. They have identified sets
of phages that target clinically-relevant and prevalent strains. Despite the most effective phage set
being isolated from one geographical location, they are strikingly variable (Figure 3) with very few
identifiable genes in common.
Martha Clokie’s group is currently in the process of creating and examining genetic mutants to
identify phenotypes and conducting structural work on novel proteins, for example to identify tail
fibres. However, this work is time consuming and technically demanding. Choosing which genes
to focus on is key, as downstream work is key to unravelling critical phenotypes. Martha Clokie
presented data on the efficacy of this phage set to treat disease along with a framework for their
ongoing work to use different machine learning approaches to examine the genomes of these phages
and their associated bacteria robustly in order to identify hard-to-identify features, for example shared
and unique genes of interest. These approaches will direct work to unravel the mechanics of phage
efficacy for virulent phages and modes of action for lysogens.
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Figure 3. Set of Clostridium difficile phages on the vertical axis, which includes six well-characterised
myoviruses from Martha Clokies’ laboratory (red dots). The genes commonly identified in C. difficile
phages are shown on the horizontal axis and homologous genes represented by a green line. It is clear
that these phages do not share a large common gene set.
2.2.2. Global Phylogeography and Ancient Evolution of the Widespread Human Gut Virus
crAssphage, by Bas E. Dutilh
While viruses are vastly abundant and ubiquitous throughout the biosphere, they have remained
a relatively unexplored superkingdom of life. Early findings of genomic mosaicism [18] and
enhanced mutation rates of especially RNA viruses [19] have led to the conception of viruses as
genomically highly variable entities. This was further supported as metagenomics unveiled the
extent of genetic diversity of viruses, initially in marine water and human faeces [20], and in many
different biomes since. Images of an unparalleled diversity that is dominated by unknown sequences
has been the common theme of viral metagenomic explorations. However, while the virosphere is
undoubtedly diverse, ubiquitous viruses are increasingly being discovered by metagenomic analysis
of globally-distributed, ecologically-stable ecosystems, including once again the global oceans [21,22]
and the human gut [23–25].
Moreover, the genome sequence in individual viral lineages may be more conserved than could
previously be recognized. Recently, large-scale comparisons of gene order in the genome sequences
of dsDNA bacteriophages revealed a surprisingly conserved genomic structure [26,27]. A possible
mechanism at play is the genomic encoding of different transcriptional regions with promoters that
govern the expression of early, middle and late specific genes, such as known from the well-studied case
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of the T4 bacteriophage [28]. Together, these findings suggest a highly-optimized genomic encoding of
gene expression regulation that is consistent across globally-diverse viral populations.
While the conservation of genomic architecture between distantly-related bacteriophages as
outlined above is a striking observation, many open questions remain. For example, it remains unclear
to what extent the observations of conserved genomic architecture described above reflect a biased
sampling, for example of temperate, dsDNA and/or tailed bacteriophages that have been observed
to dominate, e.g., marine systems [29]. Indeed, the modes of genome evolution differ for viruses
with different lifestyles [30]. Nevertheless, viruses have vast global population sizes that result in
highly-efficient evolutionary selection pressures and optimized genomes. Moreover, viruses and their
cellular hosts have been co-evolving for billions of years, allowing ample time for optimization of their
genome structures.
Viral mutation rates (including recombination rates) have remained difficult to quantify due to a
lack of evolutionary calibration points. For example, on a short time scale of thirty years, a constant
recombination rate of five events per year has been observed for Siphoviridae bacteriophages [31],
but when longer timespans are assessed, mutation rate estimates may drop dramatically by orders
of magnitude [32]. One way of obtaining ancient calibration points in viral evolution in the absence
of fossil data is by exploiting their association to hosts. One of the most conserved constituents of
the human gut virome is the widespread and abundant bacteriophage crAssphage [23]. Recently,
near-complete genome sequences of crAss-like viruses were detected in faecal samples of a range of
wild non-human primates living on different continents, including Old-World monkeys, New-World
monkeys and apes [33]. Strikingly, these genomes revealed a strong collinearity with human-associated
crAss-like viruses, suggesting that the association of crAss-like viruses with the primate gut biome may
be millions of years old. Moreover, these findings open the door to investigations into viral mutation
rates at long time-scales, once again illustrating how viral metagenomics opens up a treasure trove for
virus discovery [34], as well as evolutionary analyses of these smallest and most abundant biological
entities on Earth.
2.2.3. Genome-Resolved Metaviromics for the Detection of Pathogenic Viruses in the Environment:
Will Eating Shellfish Make You Ill?, by Evelien M. Adriaenssens
Viromics or viral metagenomics has been proposed as an alternative method to qPCR-based
approaches for the detection of pathogenic viruses linked to food- and water-borne illness in the
aquatic environment [35,36]. The main advantage is that viral communities can be investigated
without prior knowledge of the genome sequences or genotypes of the viruses present in the sample.
There are, however, several drawbacks associated with viromics, such as laboratory and computational
costs, scalability and the issue of viral dark matter in which sequence data are classified as “unknown”.
In her presentation, Evelien Adriaenssens focused on the latter aspect and showed that reconstruction
of Uncultivated Virus Genomes (UViGs) [37] and classification into families reduced the fraction
of completely unknown sequences, particularly for RNA viruses. Using read mapping approaches
followed by visualisation and analysis with Anvi’o [38], she showed that they can identify pathogenic
virus genomes present in the Conwy River catchment area, mainly found in wastewater [39], and
showed changing abundance patterns between sample sites and types. Using species-level clustering
and differential read mapping, comparative genomics and phylogenetics, she could gradually descend
from the bigger picture of viral diversity to strain-level resolution, identifying the genotype of
potentially pathogenic viruses. This workflow is ideally suited to find new pathogenic viral species
and identify markers for wastewater contamination of the environment.
Evelien M. Adriaenssens was funded by the Biotechnology and Biological Sciences Research Council
(BBSRC) under the BBSRC Institute Strategic Programme Gut Microbes and Health BB/R012490/1.
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2.3. Virus Classification and Evolution
This session was chaired by Darren Obbard (University of Edinburgh, United Kingdom).
Two speakers have been invited on this topic. Peter Simmonds (University of Oxford, United Kingdom)
presented about classification of viruses in metagenomic datasets. Unfortunately, Olga Kalinina (Max
Planck Institute for Informatics, Saarbrücken, Germany) was unable to make it to the meeting. Instead,
Manja Marz (Friedrich Schiller University Jena, Germany), Managing director of the EVBC, presented
about machine learning applied to virus data. From the submitted abstracts, we selected talks by Julian
Susat (Institute of Clinical Molecular Biology, Kiel, Germany) on the detection of viruses in ancient
human remains, Aare Abroi (University of Tartu, Estonia) on the relation between virosphere and
biosphere, and Kevin Lamkiewicz (Friedrich Schiller University Jena, Germany) on RNA secondary
structures in whole genome alignments of viruses. Based on this submission, Kevin was competitively
awarded the PhD travel award.
2.3.1. The Classification of Viruses in Metagenomic Datasets—Where Do You Draw the Line?,
by Peter Simmonds
Methodological advances, such as High-Throughput Sequencing (HTS), and new capabilities to
recover and assemble genome sequences has unearthed vast numbers of previously-undescribed
viruses from environmental, human clinical, veterinary and plant samples. How such viruses
can be incorporated into the current virus taxonomy is a major challenge, especially at the family
and species levels, which have been historically based largely on descriptive taxon definitions of
phenotypic properties that “sequence-only” viruses often lack. These assignments typically encapsulate
descriptions of replication strategies, virion structure, and clinical and epidemiological features, such
as host range, geographical distribution and disease outcomes. If “sequence-only” viruses are to be
formally placed into the classification maintained by the International Committee on the Taxonomy
of Viruses (ICTV) as recently proposed [40], then their assignments will have to be based largely
or entirely on metrics of genetic relatedness and any other features that might be inferred from
their genome sequences. However, there are no published guidelines in the ICTV code on how
similar or how divergent viruses must be in order to be considered as new species or new families
(https://talk.ictvonline.org/information/w/ictv-information/383/ictv-code).
Peter Simmonds described their investigations of the extent to which the existing virus taxonomy
could be reproduced by the recoverable genetic relationships between sequences of viruses currently
classified by the ICTV. Comparisons of viruses were based on extraction of protein coding gene
signatures and genome organisational features from virus sequences and using these to construct
a metric of genetic relatedness through computation of Composite Generalised Jaccard (CGJ)
distances between each pair of viruses [41]. For eukaryotic viruses, there was large-scale consistency
between such genetic relationships and their current family- and genus-level taxonomic assignments,
irrespective of genome configurations and genome sizes. The analysis pipeline, “Genome Relationships
Applied to Virus Taxonomy” (GRAViTy), diagrammatically summarised in Figure 4, predicted family
membership of eukaryotic viruses with close to 100% accuracy and specificity; this method should
therefore enable the vast collection of metagenomic sequences to be classified in a manner consistent
with the current ICTV taxonomy. Preliminary analysis of such datasets revealed that over one half
(460/921) of (near)-complete genome sequences from recently-generated eukaryotic virus datasets
could be assigned to 127 novel family-level groupings, more than double the number of eukaryotic
virus families in the ICTV taxonomy.
The taxonomy of the 20 currently-classified prokaryotic virus families differs substantially [42].
Members of three families in particular (Podoviridae, Siphoviridae and Myoviridae) were far more
divergent from each other than observed within eukaryotic and archaeal virus families. Applying a
CGJ distance threshold of 0.8, prokaryotic viruses form over 100 groupings equivalent to eukaryotic
virus families. The use of a common benchmark with which to compare taxonomies of eukaryotic and
prokaryotic viruses supports ongoing efforts by the ICTV to revise thoroughly the phage taxonomy so
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that assignment criteria are consistent across all virus groups. Developing a consistent classification of
viruses in which assignments at family and other taxonomic levels extending the current framework,
but which will be underpinned both by metrics of genomic relatedness, is essential for future,
evidence-based classification of metagenomic viruses.
Figure 4. Overview of virus taxonomy prediction by “Genome Relationships Applied to Virus
Taxonomy” (GRAViTy). A simplified diagram of the steps used to construct profile tables from
sequences of viruses with assigned taxonomic status (reference virus genomes). It further illustrates the
steps to classify viruses of of undetermined taxonomic relationships. The method is based on extraction
of protein sequences from reference virus genomes and their clustering using pairwise BLASTp bit
scores. Sequences in each cluster are then aligned and turned into a Protein Profile Hidden Markov
Model (PPHMM). Reference genomes are subsequently scanned against the database of PPHMMs
to determine the locations of their genes, and Genomic Organisation Models (GOMs) for each virus
family are constructed. These models form the core of the genome annotator (Annotator), which is used
to annotate query sequences with information on the presence of genes and the degree of similarity
of their genomic organisation to reference virus sequences. From this, genome relationships can be
extracted by computation of various genetic distance metrics, including composite generalised Jaccard
similarity, which forms the basis for heat maps and dendrograms that depict the relationships of query
sequences to the dataset of classified viruses (Classifier) and recommendations for their taxonomic
assignments (Evaluator).
2.3.2. Detecting Viruses in Ancient Human Remains, by Julian Susat
The field of ancient DNA covers a wide range of research topics, spanning from human evolution,
megafauna to pathogen evolution. Despite the recent advantages in ancient DNA techniques and
modern metagenomic screening tools, the identification of authentic viral sequences from ancient
material is still challenging. The materials that are mainly used in ancient DNA research, teeth and
petrous bones, already limit the number of detectable viruses by their nature. Only viruses that
are present in the bloodstream can be detected. The fast evolution of viral pathogens and therefore
the comparability to modern variability in viruses makes it even more difficult to identify their
ancestors reliably. The highly-fragmented and degraded nature of ancient genetic material and the
high risk of modern contamination are causing further problems in the analysis. For the detection
of viruses, a wide variety of software utilizing different approaches like HMMs, dedicated marker
genes and complete genome references are available to screen these ancient samples for the presence
of pathogens. Each of these approaches has its own characteristic strengths and weaknesses. In a
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competitive alignment approach using all complete virus genomes as a reference, we were able to
detect three Hepatitis-B Viruses (HBV) during our regular screening. All three samples originated
in Germany and dated to the mediaeval times (1000 BP) and the Neolithic (5000 and 7000 BP). After
sequencing and competitive mapping against 16 HBV references, complete HBV genomes could be
recovered from all three samples. This resulted in the oldest human pathogenic viral genome that
is known up to know. Phylogenetic analysis revealed that the medieval strain was genotype D and
surprisingly conserved. The ancient Neolithic strains were closer together than to any other modern
and closest to strains from Old-World monkeys. These findings might suggest reciprocal cross-species
transmission between human and ape. Furthermore, we could show that the genomic structure of
ancient strains closely resembles the structure of modern HBV strains. Since publishing these results,
we and others detected more HBV-positive samples, supporting the notion that viruses will become
more important for the aDNAcommunity (Figure 5). The new HBV genomes we reconstructed support
our earlier findings. A bigger number of HBV cases spanning over longer time frames opens the door
for reliable diachronic analysis and maybe even epidemiological analysis. Besides the recent findings of
ancient viruses (e.g., Parvovirus), an open question still remains how we could detect and reconstruct
extinct or highly-altered virus genomes. Bioinformatic protocols for the detection of unknown viral
protein families based on long sequencing reads and high coverage data are published and available,
but due to the above-described nature of aDNA, applying these methods is not straightforward, and
strong optimization needs to be carried out. Still, these HBV and other findings have opened a new
door within the aDNA community and blazed a trail for upcoming viral ancient DNA studies. This
work was done by a team composed of Ben Krause-Kyora, Julian Susat, Felix M. Key, Denise Kühnert,
Alexander Immel, Alexander Herbig, Almut Nebel and Johannes Krause.
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Figure 5. Network of 493 modern genomes, 15 published ancient strains and 12 newly-discovered
ancient strains. Single letters indicate HBV genotypes (A–H); coloured strains are of ancient origin;
OWM = Old-World Monkey HBV strains, NWM = New-World Monkey HBV strains. D: five new
ancient strains, six ancient strains [43–45]; C: one ancient strain [46]; B: one ancient strain [45]; A: two
new ancient strains, three ancient strains [45]; G: one new ancient strain; OWM: three new ancient
strains, four ancient strains [44,45].
2.3.3. Virosphere and Biosphere—How Related They Are? A Protein (Domain) Based View, by
Aare Abroi
Viruses are not always pathogens, and they are also an important and inseparable part of the
biosphere and should be studied as such. Unfortunately, the wider functional and evolutionary
role of viruses in the biosphere is not yet widely accepted in most disciplines, a good exception
being marine biology/ecology, where viruses are already accepted as important players. How the
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virosphere is related to the rest of the biosphere can be examined in several different ways. One of
these ways is a protein domain-based view. We analysed how virosphere protein domain occurrence
is related to the occurrence of protein domains in all (sequenced) organisms (we called the last the
phylogenomic space of protein domains). This is based on the distribution of protein domains in
viruses and in organisms (by superkingdom), i.e., which protein domains are found in viruses (or a
specific set of viruses) and to what extent and where these domains are found elsewhere in organisms.
In our analysis, we used predefined protein domain databases Pfam, Superfamily and Gene3D.
Domains found in the virosphere can be found in a different number of organisms, starting from a few
organisms for some viral domains up to all organisms in the others. However, if we specify a narrower
set of viruses (Baltimore class, viral family or host range), differences between viral taxons appear.
Therefore, the heterogeneity of viruses is also very clearly expressed by where in the phylogenomic
space the domains that are found in different viral taxons are located. A few examples are shown in
Figure 6. An important conclusion from our analysis is the existence of virosphere-specific protein
domains (domains not found in cellular organisms), even at the level of structural homology. Several
evolutionary routes that may lead to virosphere specificity (absence in cellular organisms) will be
discussed. Considering the new knowledge on virus-to-host gene transfers in eukaryotes during
the last ten years, it is clear that the virosphere is a source of functional and structural novelties
also for this superkingdom. A possible route for the genesis of novel domains in viruses (as well
as in organisms) is double coding or overprinted genes. We have developed a web-tool cRegions
(http://bioinfo.ut.ee/cRegions/), which helps to find potential double coding regions (and other
embedded functional elements) in coding sequences [47,48]. Of course, there exist many domains that
are shared by viruses and organisms. Beside others, virus-to-host gene transfer is one process leading
to shared domains. A number of examples for this kind of transfer have been described; however,
they are all based on sequence-to-sequence comparison. Taking into account the very fast evolution
of viruses, the sequence similarity may fall below the confidential detection limit relatively fast. We
applied structure-guided information to detect more ancestral virus-to-host transfers. Our data show
that “as a proof of principle”, using protein structure-guided HMM models, it is possible to detect
V2Htransfers not “visible”; with BLAST analysis.
Figure 6. Distribution of the protein domains found in three viral families according to their occurrence
in different superkingdoms. Protein domains as they are defined in SCOPat the superfamily level and
the occurrence of these domains according to Superfamily assignment (www.supfam.org). For example,
Coronaviridae encodes 13 protein domains not found in eukaryotic genomes and nine domains found
in more than 90% of eukaryotic genomes.
2.3.4. RNA Secondary Structures in Whole Genome Alignments of Viruses, by Kevin Lamkiewicz
RNA secondary structures are known to play important roles in viruses, and especially in
RNA viruses, since they can initiate and facilitate transcription, translation and replication. Several
studies indicate that structures are cis-acting regulators for transcription. However, only looking at
local structures is not sufficient to capture all RNA–RNA interactions of one molecule. Long-Range
Interactions (LRI) are described in a few RNA virus families [49], but are computationally intensive
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to predict. Further, studies show that a single nucleotide changing can disrupt the replication of a
coronavirus completely [50]. Thus, a deep understanding of conserved RNA structures is necessary to
develop anti-viral therapies.
In order to increase the confidence of predictions, Multiple Sequence Alignments (MSA) are
needed, since they provide conservation information between viruses. Identifying conserved secondary
structures in whole genomes of viruses is computationally challenging, as the whole genome has to be
considered for possible structures and interactions.
Here, we give an overview of the landscape of RNA secondary structures in viruses and provide
a pipeline that generates whole genome alignments with structure annotation for downstream
analyses. Our pipeline distinguishes itself from other tools by considering both the sequence and
structure of input genomes for the final alignment. Therefore, for the first time, the generation of
structure-annotated whole genome alignments for viruses enables sophisticated and comprehensive
downstream analysis for RNA structures and RNA functions. This is achieved with an iterative
combination of the sequence-based aligner MAFFT [51] and the structure-based aligner LocARNA [52].
For our example case, we were able to predict structures in the genus Flavivirus [53] that are consistent
with described structures in the literature (Figure 7). Further, we predicted novel structural elements
in coding regions of genomes.
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Figure 7. First results of our VeGETApipeline on an example input set consisting of flaviviruses.
We were able to identify the West-Nile Virus (WNV), Dengue Virus 1 (DENV1), Japanese Encephalitis
Virus (JEV), Yellow Fever Virus (YFW), Saint Louis Encephalitis Virus (SLEV) and Murray
Valley Encephalitis Virus (MVEV) as representative viruses from downloaded virus genomes [53].
The resulting alignment calculated by VeGETA has structure annotations for the complete genomes,
including 5’ UTR, coding regions and 3’ UTR. Here, we extracted the 5’ UTR from the alignment
and visualized the annotated structure elements. These elements agree with the literature [54], as we
were able to reconstruct the SLA, SLL, SLBand cHPelements accurately. The first two elements were
recognized by the viral replication mechanism (NS5) [55]. The sequence embedded in the SLB structure
is known to play a role in the genome circularization of flaviviruses [56], whereas the cHP facilitates the
translation of the coding region by pausing the translation machinery and finding the correct starting
triplet [57].
2.4. Epidemiology, Surveillance and Evolution
This session was chaired by Edward Hutchinson (MRC-University of Glasgow Centre for Virus
Research, United Kingdom). Two speakers have been invited on this topic. Samantha Lycett (University
of Edinburgh, United Kingdom) presented about phylodynamics for tracking epidemic, endemic
and evolving viral strains. Roman Biek (University of Glasgow, United Kingdom) presented about
leveraging pathogen genomics to reveal and control the spread of rabies virus. From the submitted
abstracts, we selected talks by Marina Escalera-Zamudio (University of Oxford, United Kingdom) on
parallel evolution and the emergence of highly-pathogenic avian influenza A viruses, David Bauer
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(University of Oxford, United Kingdom) on the structure of the influenza A virus genome and Lu
Lu (University of Edinburgh, United Kingdom) on the evolutionary origins of the epidemic potential
among human RNA viruses.
2.4.1. Phylodynamics for Tracking Epidemic, Endemic and Evolving Viral Strains, by Samantha Lycett
Infectious diseases caused by viral pathogens in animal and livestock populations can have
important economic and health consequences globally. The ability to foresee where, in which host
species and under what conditions outbreaks could occur is key to developing prevention and control
strategies. Sequencing pathogens from infected animals has become much more affordable and
widespread in recent years, especially during outbreaks and in endemic disease settings with targeted
surveillance programmes. Consequently, there are growing collections of animal virus sequences
from around the globe. In this talk, the use of viral sequence data together with phylodynamic
methodologies for understanding the transmission patterns in animal populations was discussed,
using Avian Influenza (AI), Foot-and-Mouth Disease (FMD) and Porcine Reproductive and Respiratory
Syndrome (PRRS) as examples [58–60].
Since RNA viruses have fast mutation rates and variable sequences, transmission routes between
places and host species can be inferred [59,60]. One approach is to group sequences from individual
hosts into discrete locations and/or host species and consider these as discrete traits or subpopulations
on time-resolved phylogenetic trees, with the goal to infer which group infected which. Alternatively,
locations may be represented as continuous traits (latitude and longitude) in order to estimate spatial
diffusion rates and routes.
Using avian influenza as an example of a widespread multi-species disease system, it was shown
that wild birds (wild Anseriformes) were responsible for long-range transmissions of highly-pathogenic
H5N8, by using a combination of discrete host traits and continuous spatial traits on time-resolved
phylogenetic trees [58]. Furthermore the clade to which the H5N8 strains belong is unusual
because unlike the highly-pathogenic H5N1 strains, they reassort frequently, picking up different
neuraminidase subtypes. By using both host and neuraminidase subtype as discrete traits, it was also
shown that reassortment was preferentially occurring in Anseriformes species (ducks, geese, etc.).
To conclude, phylodynamic methods using viral sequence data with time, space and species
metadata reveal complex transmission patterns and can be used to understand, track, model and
ultimately inform disease control measures.
2.4.2. Parallel Evolution and the Emergence of Highly-Pathogenic Avian Influenza A Viruses,
by Marina Escalera-Zamudio
Avian Influenza A Viruses (AIVs) circulate among wild and domestic bird populations worldwide.
While some strains only cause mild to asymptomatic infections, known as Low Pathogenicity avian
influenza viruses (LP), High Pathogenicity avian influenza viruses (HP) can have an extremely
high mortality rate in both domestic and wild bird populations, leading to huge economic loses
(Figure 8A) [61]. Thus, surveillance of AIVs is crucial for early detection of outbreaks. Although
virulence is a polygenic trait, molecular determinants of virulence have been well characterised for
AIVs, such as a polybasic proteolytic cleavage site within the hemagglutinin protein, which enables a
systemic viral spread within the host [62]. We hypothesise that the parallel evolution of HP lineages
from LP ancestors may have been facilitated by permissive or compensatory secondary mutations
occurring anywhere in the viral genome, preceding or following the appearance of a polybasic
proteolytic cleavage site. We used a comparative phylogenetic and structural approach to detect shared
mutations evolving under positive selection across the whole genome of HP AIVs of the H7NX and
H5NX subtypes and developed a model that statistically assesses genotype-phenotype associations.
We present cumulative evolutionary and structural evidence that supports the association between
parallel mutations and the evolution of the HP phenotype. Parallel mutations occur frequently among
HP lineages of the same viral subtype (Figure 8B). Many of the mutations have been previously
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determined to increase viral fitness in terms of their biological properties, whilst most of these are
ranked as stabilising to protein structure, supporting that these are rather permissive/compensatory.
The mutational panel provided here may function as an early detection system for transitional virulence
stages. Circulating AIVs that do not have a polybasic cleavage site yet, but show all or some of the
amino acid changes ranked, should remain under surveillance.
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Figure 8. (A) Geographical occurrence of historic Highly-Pathogenic (HP) outbreaks for the H7NX
viruses. Countries of emergence are highlighted in red. Year of circulation, virus subtype and
consensus sequence for the polybasic Cleavage Site (pCS) within the Hemagglutinin (HA) protein
are indicated for the selected outbreaks used in this work (C1-C9). Each outbreak corresponds to a
distinct genotype, defined as well- supported clusters within all viral genome segment trees (data
not shown). (B) MCCtree for the HA protein with reconstruction of ancestral states for site 143, as
mutation A143T was found to be evolving under parallel evolution and to be associated with the HP
phenotype, occurring in 4/9 of the HP clusters analysed. This mutation is a non-conservative amino
acid change located within an antigenic pocket site. Branches within the trees are coloured according
to the corresponding amino acid states in nodes (tip states not shown). Ancestral nodes preceding the
emergence of a mutation associated with the HP lineages are represented with coloured circles. The
probabilities of a given amino acid state occurring within ancestral/descending nodes are indicated.
The HP clusters of interest are highlighted with blue circles. Mutations strongly associated with an HP
phenotype may function as an early detection system for transitional virulence stages.
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2.4.3. Evolutionary Origins of Epidemic Potential among Human RNA Viruses, by Lu Lu
For a virus to have epidemic potential in human populations, an infected individual must be
capable of transmitting the infection to other individuals. However, for the majority of human RNA
virus species, human infections are acquired only from non-human reservoirs. The evolution of human
transmissibility is poorly understood. Through parallel analyses of 1755 RNA viruses, we identified
at least 90 nodes across 39 genus-level phylogenies associated with transitions involving the gain of
human infectivity and/or transmissibility. Human-infective and human-transmissible viruses evolve
independently, and at least 73% of human-transmissible RNA virus lineages emerged directly from
non-human virus lineages in diverse mammal or bird taxa. Negative sense single-stranded RNA virus
lineages generate a higher proportion of strictly zoonotic viruses. Our analysis demonstrates that RNA
viruses from mammal/bird lineages not currently known to be infective to humans are a likely source
of future epidemics in human populations, a public health threat recently designated “Disease X”.
3. Poster Session
Another important facet of this year’s annual EVBC meeting was the poster session on Thursday
evening. The standard of the research presented was extremely high and, combined with a networking
event in the Glasgow University Union, provided plenty of opportunity to meet the presenters.
The relaxed atmosphere was instrumental to promoting discussions and developing new interactions
between attendees. The list of poster presenters and titles can be found online (http://evbc.uni-jena.
de/events/3rd-evbc-meeting).
4. Conclusions
The Third Annual Meeting of the European Virus Bioinformatics Center brought together scientists
in the field with expertise in different disciplines for scientific exchange and provided the opportunity
for discussing ongoing and new collaborations. The meeting attracted new researchers to virus
bioinformatics, which was reflected by several first-time attendees. The presentations strongly
underlined the interdisciplinary “virology meets bioinformatics” character of the meeting. We enjoyed
lively discussions after the speakers’ presentations, in the breaks, during the poster session and at the
social events.
We hope that speakers summaries provided in this report will give an interesting insight into
the field of virus bioinformatics and will encourage interested researchers to join us at the Fourth
Annual Meeting of the EVBC to be held in Switzerland in 2020. For more information, do not hesitate
to contact us via evbc@uni-jena.de.
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